Michael Aschner
Yeshiva University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Aschner.
Archives of Toxicology | 2016
Patrícia Reckziegel; Pan Chen; Sam Caito; Priscila Gubert; Félix Alexandre Antunes Soares; Roselei Fachinetto; Michael Aschner
AbstractnReserpine is used as an animal model of parkinsonism. We hypothesized that the involuntary movements induced by reserpine in rodents are induced by dopaminergic toxicity caused by extracellular dopamine accumulation. The present study tested the effects of reserpine on the dopaminergic system in Caenorhabditis elegans. Reserpine was toxic to worms (decreased the survival, food intake, development and changed egg laying and defecation cycles). In addition, reserpine increased the worms’ locomotor rate on food and decreased dopamine levels. Morphological evaluations of dopaminergic CEP neurons confirmed neurodegeneration characterized by decreased fluorescence intensity and the number of worms with intact CEP neurons, and increased number of shrunken somas per worm. These effects were unrelated to reserpine’s effect on decreased expression of the dopamine transporter, dat-1. Interestingly, the locomotor rate on food and the neurodegenerative parameters fully recovered to basal conditions upon reserpine withdrawal. Furthermore, reserpine decreased survival in vesicular monoamine transporter and dat-1 loss-of-function mutant worms. In addition, worms pre-exposed to dopamine followed by exposure to reserpine had decreased survival. Reserpine activated gst-4, which controls a phase II detoxification enzymes downstream of nuclear factor (erythroid-derived-2)-like 2. Our findings establish that the dopamine transporter, dat-1, plays an important role in reserpine toxicity, likely by increasing extracellular dopamine concentrations.
Toxicology and Applied Pharmacology | 2018
Ellen Fritsche; Philippe Grandjean; Kevin M. Crofton; Michael Aschner; Alan M. Goldberg; Tuula Heinonen; Ellen V.S. Hessel; Helena T. Hogberg; Susanne Hougaard Bennekou; Pamela J. Lein; Marcel Leist; William R. Mundy; Martin Paparella; Aldert H. Piersma; Magdalini Sachana; Gabriele Schmuck; Roland Solecki; Andrea Terron; Florianne Monnet-Tschudi; Martin F. Wilks; Hilda Witters; Marie-Gabrielle Zurich; Anna Bal-Price
This consensus statement voices the agreement of scientific stakeholders from regulatory agencies, academia and industry that a new framework needs adopting for assessment of chemicals with the potential to disrupt brain development. An increased prevalence of neurodevelopmental disorders in children has been observed that cannot solely be explained by genetics and recently pre- and postnatal exposure to environmental chemicals has been suspected as a causal factor. There is only very limited information on neurodevelopmental toxicity, leaving thousands of chemicals, that are present in the environment, with high uncertainty concerning their developmental neurotoxicity (DNT) potential. Closing this data gap with the current test guideline approach is not feasible, because the in vivo bioassays are far too resource-intensive concerning time, money and number of animals. A variety of in vitro methods are now available, that have the potential to close this data gap by permitting mode-of-action-based DNT testing employing human stem cells-derived neuronal/glial models. In vitro DNT data together with in silico approaches will in the future allow development of predictive models for DNT effects. The ultimate application goals of these new approach methods for DNT testing are their usage for different regulatory purposes.
Toxicology | 2016
Michael Aschner; Herman Autrup; Sir Colin Berry; Alan R. Boobis; Samuel M. Cohen; Edmond E. Creppy; Wolfgang Dekant; John Doull; C. Galli; Jay I. Goodman; Gio Batta Gori; Helmut Greim; Philippe Joudrier; Norbert E. Kaminski; Curtis D. Klaassen; James E. Klaunig; Marcello Lotti; Hans Marquardt; Olavi Pelkonen; I. Glenn Sipes; Kendall B. Wallace; Hiroshi Yamazaki
A public appeal has been advanced by a large group of scientists, concerned that science has been misused in attempting to quantify and regulate unmeasurable hazards and risks.1 The appeal recalls that science is unable to evaluate hazards that cannot be measured, and that science in such cases should not be invoked to justify risk assessments in health, safety and environmental regulations. The appeal also notes that most national and international statutes delineating the discretion of regulators are ambiguous about what rules of evidence ought to apply. Those statutes should be revised to ensure that the evidence for regulatory action is grounded on the standards of the scientific method, whenever feasible. When independent scientific evidence is not possible, policies and regulations should be informed by publicly debated trade-offs between socially desirable uses and social perceptions of affordable precaution. This article explores the premises, implications and actions supporting the appeal and its objectives.
Elsevier Inc. | 2014
S. Caito; Lucio Guido Costa; Michael Aschner
Metals are the most common elements in our environment. While several metals serve physiological roles, both essential and nonessential metals pose significant health risks upon acute and chronic exposure to high levels. Herein, we discuss sources of metal exposure, effects on human health, detoxification, and molecular mechanisms of metal-induced toxicity.
Elsevier Inc. | 1987
Lucio G. Costa; Michael Aschner
Pesticides are chemicals deliberately added to the environment for the purpose of killing or injuring pests (insects, rodents, weeds, and other unwanted organisms). While many pesticides are toxic only to target species, many are not highly selective, and are also toxic to nontarget species, including humans. Several classes of pesticides exist, with different uses, mechanisms, and toxic effects. Major classes of pesticides are insecticides, herbicides, fungicides, and rodenticides.
Archive | 2005
Michael Aschner; Lucio G. Costa
Environmental Factors in Neurodevelopmental and Neurodegenerative Disorders | 2015
Michael Aschner; Lucio G. Costa
Archive | 2004
Michael Aschner; Lucio G. Costa
Archive | 2004
Lucio G. Costa; Michael Aschner
Archive | 2015
Michael Aschner; Lucio G. Costa